| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.683 | 1.710 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 2.912 | 1.854 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 3.897 | 3.262 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -985 | -1.408 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -1.072 | -1.463 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ebifarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 9 | 9 |
| Current Assets | 2.010 | 1.205 | 1.185 | 1.163 | 1.140 | 1.119 | 1.094 | 663 | 661 | 658 |
| Inventories | 1.700 | 958 | 942 | 925 | 907 | 890 | 870 | 439 | 437 | 435 |
| Receivables | 312 | 228 | 224 | 220 | 216 | 211 | 207 | 207 | 207 | 206 |
| Cash | -3 | 19 | 18 | 18 | 18 | 17 | 17 | 17 | 17 | 17 |
| Shareholders Funds | -2.751 | -4.187 | -4.116 | -4.040 | -3.962 | -3.887 | -3.801 | -3.813 | -3.801 | -3.780 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 4.771 | 5.402 | 5.310 | 5.213 | 5.112 | 5.015 | 4.904 | 4.485 | 4.471 | 4.446 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Ebifarm Srl